Doravirine / lamivudine / tenofovir disoproxil fumarate (Delstrigo®) recommended as an option for use within NHS Wales

An option for use within NHS Wales for the treatment of adults infected with HIV-1 without past or present evidence of resistance to the non-nucleoside reverse transcriptase inhibitor class, lamivudine, or tenofovir.

All Wales Medicines Strategy Group